The Application of Dupilumab to Pediatric Patients Aged 6–11yrs with Moderate-to-Severe Atopic Dermatitis Whose Disease is Not Adequately Controlled: The Clinical Data so Far

BACKGROUND: While dupilumab has shown efficacy in improving atopic dermatitis, few studies have assessed the long-term clinical data of dupilumab use in pediatric patients. OBJECTIVE: In the present study, we reviewed the current literature to assess reported efficacies, side effects, and risks of u...

Descripción completa

Detalles Bibliográficos
Autores principales: Balboul, Sarah, Kahn, Julia, Tracy, Alexis, Peacock, Anjelica, Cline, Abigail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162094/
https://www.ncbi.nlm.nih.gov/pubmed/37152103
http://dx.doi.org/10.2147/DDDT.S281626

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162094/
https://www.ncbi.nlm.nih.gov/pubmed/37152103
http://dx.doi.org/10.2147/DDDT.S281626

Ejemplares similares